www.fdanews.com/articles/134648-seattle-genetics-seeks-tumor-drug-nod
Seattle Genetics Seeks Tumor Drug Nod
February 28, 2011
Seattle Genetics Inc. has submitted a request to the U.S. Food and Drug Administration to use the company’s antibody drug to treat relapses in Hodgkin lymphoma, the Bothell, Wash.-based company announced today.
Puget Sound Business Journal
Puget Sound Business Journal